Cancer costs EU $170 bln annually: study

ПОДЕЛИТЬСЯ

Cancer costs EU $170 bln annually: study

Cancer cost the then 27 countries of the European Union 126 billion euros ($170.1 billion) in 2009, AFP reports according to a study published on Monday. The bill mainly comprised 51 billion euros in costs for health-scare systems, including drugs; 23 billion euros in unpaid care provided by friends and relatives of people with cancer; and 52 billion euros in lost productivity due to premature deaths and illness. Britain, France, Germany and Italy accounted for most than two-thirds of the cost. Four types of cancer -- breast, colorectal, lung and prostate -- contributed to around half of all new cancer diagnoses and deaths. Lung cancer had the highest overall cost, of 18.8 billion euros, and was also responsible for the biggest loss of productivity. The analysis should be useful for policymakers weighing decisions on where to allocate research funds, drugs and human resources, said researcher Ramon Luengo-Fernandez of the University of Oxford. The study appears in The Lancet Oncology.

ПОДЕЛИТЬСЯ
Cancer cost the then 27 countries of the European Union 126 billion euros ($170.1 billion) in 2009, AFP reports according to a study published on Monday. The bill mainly comprised 51 billion euros in costs for health-scare systems, including drugs; 23 billion euros in unpaid care provided by friends and relatives of people with cancer; and 52 billion euros in lost productivity due to premature deaths and illness. Britain, France, Germany and Italy accounted for most than two-thirds of the cost. Four types of cancer -- breast, colorectal, lung and prostate -- contributed to around half of all new cancer diagnoses and deaths. Lung cancer had the highest overall cost, of 18.8 billion euros, and was also responsible for the biggest loss of productivity. The analysis should be useful for policymakers weighing decisions on where to allocate research funds, drugs and human resources, said researcher Ramon Luengo-Fernandez of the University of Oxford. The study appears in The Lancet Oncology.
Tengrinews
Читайте также
Join Telegram
Arctic cold approaches Kazakhstan
Earthquake felt by residents of Almaty
Kazakhstan to be hit by snowfall
Flights delayed at Aktobe airport
US dollar drops sharply in Kazakhstan
Kazakhstan to raise living wage in 2026
Tenge continues to strengthen steadily
CSTO meeting has begun in Bishkek

Exchange Rates

 504.61  course up  587.93  course up  6.63  course up

 

Weather

location-current
Алматы

 

Редакция Advertising
Социальные сети